{"name":"Oncopeptides AB","slug":"oncopeptides-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2021-01-01","label":"Pepaxto first approved","drug":"Pepaxto","drugSlug":"melphalan-flufenamide","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Melflufen","genericName":"Melflufen","slug":"melflufen","indication":"Relapsed or refractory multiple myeloma","status":"discontinued"},{"name":"Pepaxto","genericName":"MELPHALAN FLUFENAMIDE","slug":"melphalan-flufenamide","indication":"Relapsed or refractory multiple myeloma","status":"marketed"}]}],"pipeline":[{"name":"Melflufen","genericName":"Melflufen","slug":"melflufen","phase":"discontinued","mechanism":"Small molecule","indications":["Relapsed or refractory multiple myeloma"],"catalyst":""},{"name":"Pepaxto","genericName":"MELPHALAN FLUFENAMIDE","slug":"melphalan-flufenamide","phase":"marketed","mechanism":"Small molecule","indications":["Relapsed or refractory multiple myeloma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE1fTDNuVlFUY1hlRDNLRmR6a2NELWFfTy00XzVUTzRsajAybEp0SGEyLW5fNl96bzhQbmhJcnBXSXViLTQ2MXBETWZpeDE1YWF3LTN1dkh0S0RLakJCWmNoMXNnWGc?oc=5","date":"2026-04-01","type":"pipeline","source":"GuruFocus","summary":"OSTO Stocks: Research Stocks from OSTO - GuruFocus","headline":"OSTO Stocks: Research Stocks from OSTO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5oM3NoOENCUjNiVnZ6aTZBcDIyMTNVc2Y5YkhBczdSdnJMUDQ1R2Fqd1poVHhSb3g1MGtsR3pXTzJ2WkVrMmNnQzRjcTBiSFo2SWNJcHJ5Wm5YNGRPdVJBSHpndjRST0ZDRjEw?oc=5","date":"2026-03-15","type":"pipeline","source":"Biostock","summary":"Report: Nordic Life Science Weekly | 2026:11 - Biostock","headline":"Report: Nordic Life Science Weekly | 2026:11","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQaUFDaE9saF9QdWp1aHlnYnZOaldQYkgtdXNhVDVGSGJUTUFWUXdVbHRTTmc2WGFmVGdJRUdFcUhoTTE1S2V5bXpKbHJOdm9kV29EOWV5eDFmeUFjYjRsUFc5X3g1YUxJZ25lbmZPdURQQWZnZWVmQjNqa1FDSnRMd0o3cWZERmo1Mkt6MWlEOC1qQXJvSy1obTh0a0pJSFpfaU1TX2hVeFhwUUhmWE0zNHV0WXpCd3VHZGwwaWxjX0xZOTJBcHY5UHlKR0htc2tidHJycjQxTW_SAd4BQVVfeXFMTnI3Ni1nWEt5bUpQQ09CbGc1VDRFb2NTS2pMNS12N0Z5eTgyU2tCMkZQNkdTOV9EejFPRHIxcFZ2aVgtUW0wVGl4QlBWUk1VblNkRERlUW5ISWRGQVVSam4xX2tQSjJCaXU3YS11Yi1SV2dmSlJiQ1RRX2RnYTF3VkpPWGZ2Rkw2anhLYm9ybm1UNVBzekE5SlJ5NVp2RExGaHBXRDJndWNubDc3TVNKMjl5bHFlcXNYQXpDSEJLcm40U1BITDFweDJiWnNPSGQyYjlOdkRHazd4VU05OFB3?oc=5","date":"2026-01-13","type":"pipeline","source":"simplywall.st","summary":"Oncopeptides AB (publ) (STO:ONCO): When Will It Breakeven? - simplywall.st","headline":"Oncopeptides AB (publ) (STO:ONCO): When Will It Breakeven?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNNjN1RFdVaTE4cHJVUnBIaVJpVlBkOVhlSk9vb2FqT3A3UUtyU2UtdUJyLWJpYXZpZHc3YTd5YThCcUxXRjl3NjFudFNFdjYtSXhPd0hVclhSbUp1c2J3NDlyRExUNjhBREQ3WkFsQ3kwYlJzU3VjUHVPbDFDS25EVWRtSlpoQQ?oc=5","date":"2025-04-29","type":"pipeline","source":"Future Market Insights","summary":"AL Amyloidosis Therapeutics Market Size & Forecast 2025-2035 - Future Market Insights","headline":"AL Amyloidosis Therapeutics Market Size & Forecast 2025-2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQU1JQMGpPZjRmSldFWUJxUUNocE05LXU4VV9PdVp5U2V3cDJVa1YtRXRIYjlhbWdHY3d5a0dCd1NUUnhOUGlnRGYzcWk5d3N2eEpzNzJya21WWFRvcHBjNG1ITk5OQjFxOHl0Y3l5TXV5dGhaUDlSaWtfQ09pSGlhdWFCMmJnUHFyRG1mVU5oSVdDQQ?oc=5","date":"2025-04-21","type":"pipeline","source":"Insightace Analytic","summary":"Peptide�drug Conjugates (PDCs) Market Share, Size, Growth and Forecast to 2034 - Insightace Analytic","headline":"Peptide�drug Conjugates (PDCs) Market Share, Size, Growth and Forecast to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQLUVCTkR2aWVoSG91R2RoUUFyZUtldDE3TzBYdG55cEN5TG9ZTjdEUkNSRG1kbnUxMmVUa2hkZkhXQl9LQl9zZUNyWUx3aHBOYzRmLWMyWllFYkM5SkhuV1pGRi1YbG9oWVVGRzEyeGZ2UjN5V2VuZDhCYTNfUl9xLWt0RmJMZw?oc=5","date":"2025-01-27","type":"pipeline","source":"pharmaphorum","summary":"Italian decision sets up launch of Oncopeptides' Pepaxti - pharmaphorum","headline":"Italian decision sets up launch of Oncopeptides' Pepaxti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQTDM1LTVDNzB0YU1xUldodURyUjQ3a0Qxc0pXWTJ1M1RZdFBRSW9SN1AxZlJsWEZoSXFzTGREZ3VvR3ZZTUNBdi1RX3pXZlJLZkNQb3ViaXhCb19xZElhRzJJcjhDbTB0OEZzaWlSMHdFd0dON3NXdHJIT3JTTWFiajNJN2RDQWJVcWI3S25Jb0xBQ2c0eDl4OThMVWRIR1RoNmswNEZXTjREUGJfaGJIV1hpdmFJUVVFZ3ZB?oc=5","date":"2023-05-29","type":"regulatory","source":"Citeline News & Insights","summary":"Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else - Citeline News & Insights","headline":"Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else - Citeline News & Insights","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPUkwzLUdIUFA4RWRQWVUyb181TmphQjZ0MnByYXRNRGRvbm5HSVMzWHdVMzlUcVZEcjFzUlZZQTgwREluU0JLWmFXcV9GWGplcXhYMlRpaVIyUmpaMjlROG9CdjNVVk9ESi1nQ0lZbGJTSzJnSWd0QWxnVXJzZ25RRzBQVVFFUHNhRC1faEJaT21uZXM?oc=5","date":"2022-10-10","type":"pipeline","source":"Grand View Research","summary":"Peptide Drug Conjugates Market Size | Industry Report, 2030 - Grand View Research","headline":"Peptide Drug Conjugates Market Size | Industry Report, 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNQy1ZRVhVZXl6OG1OSm95RjBFcTFSWkt1UlBxU1JCdk16S1VmNWhPR2p3VGhUQnQyLUdOSVRabF9SZkV4WmtRWFNwb1prbWpzS0hyMEk5OUNyYTlMU0w0TzhJRV9JVlAwaWl1TFRvYW5fZlhydjNVWjM1bWZLSWZaV0R4ckhqaWpYU0Z3RHo4MDN1QUQ1X1hmblo3OENZeVE?oc=5","date":"2022-08-19","type":"pipeline","source":"pharmaphorum","summary":"Oncopeptides gets EU nod for myeloma drug Pepaxti ahead of US adcomm - pharmaphorum","headline":"Oncopeptides gets EU nod for myeloma drug Pepaxti ahead of US adcomm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOaHdUMzlib19zMG8tN2pSSmxrOWtBNjV6MFNmZ0hPNWd5OGlwLXNXN0V0cTNyUS1ITUdkaktDeTM5VHNZZTlBUExpN2owNDFpN19HWXF0SC1VQ3c4YjVaNEU1ZHdUYWFuN21tSGVaamY3WWdfb013bkI1eC14WS1VRWxlRGtYMVdhcHdyaE5vOXlRYVVaN19FY3BUNVBNNHJ6WEFubUFaSjJpRm5kYm1nXzY2OE9TcTVJeXJR?oc=5","date":"2022-06-23","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Oncopeptides’ Pepaxti wins positive opinion from CHMP for multiple myeloma patients - drugdiscoverytrends.com","headline":"Oncopeptides’ Pepaxti wins positive opinion from CHMP for multiple myeloma patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5maHBqeW9MbVVWalI3cnpSY01CTUxPOXBkcVFOTmNoSmJaREZpNjcxUFB3U2ZUOGJMaHgxNENQZmIxWDVkZ3pISTVwQThtYTlwbDAwMDBmb2phbXVZ?oc=5","date":"2018-04-14","type":"pipeline","source":"TradingView","summary":"ONCO Stock Price and Chart — OMXSTO:ONCO - TradingView","headline":"ONCO Stock Price and Chart — OMXSTO:ONCO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE5wb3BRMngtdHhNRUZyNGJmNS1zX1NwWDRpR1FMaV9NS1Q3c083eUMyZ1BObWhfQW1pazV0aHhKNXRYLURGMUFkdy1kQV9QbDBuTGpmUg?oc=5","date":"2017-05-13","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Moberg Pharma AB (publ) (MOB.ST) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Moberg Pharma AB (publ) (MOB.ST) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"discontinued":1,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}